Because GLI1 overexpression regulates the proliferation and drug sensitivity of AML cells by regulating cell cycle progression and upregulating CDKs, we hypothesized that inhibition of CDKs could reduce the adverse effects of GLI1 overexpression. This evidence concerns the gene GLI1 and acute myeloid leukemia.